Tyrosine for depression: a double-blind trial
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
We treated 65 outpatients with RDC major depression in a randomized, prospective, double-blind comparison of oral L-tyrosine, 100 mg/kg/day, imipramine, 2.5 mg/kg/day, or placebo for 4 weeks. Tyrosine increased and imipramine decreased 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion significantly, but there was no evidence that tyrosine had antidepressant activity. The only side effect to achieve statistical significance was greater dry mouth with imipramine. MHPG excretion and plasma amino acid concentrations failed to predict or correlate with clinical improvement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The HRSD is a widely used clinician administered interview assessment of depressive symptomatology (Gelenberg et al., 1990).”
From Mindfulness-Based Cognitive Therapy Improves Emotional Reactivity to Social Stress: Results from a Randomized Controlled Trial (2012) · cites this paper as Gelenberg et al., 1990
Citations
Cites
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Rapid measurement of free amino acids in serum and CSF using high-performance liquid chromatography
Fernstrom, M. H., & Fernstrom, J. D. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90669-x · Cited by 136
In search of the mode of action of antidepressants 5-HTP/tyrosine mixtures in depressions
Vanpraag, H. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90193-4 · Cited by 88
Møller, S., Kirk, L., & Honoré, P. (1980) · Journal of Affective Disorders · doi:10.1016/0165-0327(80)90021-x · Cited by 82
Tyrosine for the treatment of depression
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.5.622 · Cited by 71
Self-citationAn open trial of pargyline in the treatment of attention deficit disorder, residual type
Wender, P. H., Wood, D. R., Reimherr, F. W., & Ward, M. F. (1983) · Psychiatry Research · doi:10.1016/0165-1781(83)90006-9 · Cited by 71
Amino Acid Supplementation as Therapy for Attention Deficit Disorder
Nemzer, E., Arnold, L. E., Votolato, N. A., & McCONNELL, H. (1986) · Journal of the American Academy of Child Psychiatry · doi:10.1016/s0002-7138(10)60010-6 · Cited by 47
An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.8.1071 · Cited by 46
Gelenberg, A. J., Wojcik, J., Gibson, C. J., & Wurtman, R. J. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90019-x · Cited by 39
Self-citation
Research works printed but not linked: 1
- Mouret, 1988, La L-tyrosine guérit immediatement et à long terme, les dépressions dopamino-dépendantes, C. R. Acad. Sci. Paris, 306, 93
Cited by
Tyrosine, Phenylalanine, and Catecholamine Synthesis and Function in the Brain2
Fernstrom, J. D., & Fernstrom, M. H. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1539s · Cited by 755
Evans, D. G., & Duan, X. (2006) · Chem. Commun. · doi:10.1039/b510313b · Cited by 712
The stability of resting frontal electroencephalographic asymmetry in depression
Allen, J. J. B., Urry, H. L., Hitt, S. K., & Coan, J. A. (2004) · Psychophysiology · doi:10.1111/j.1469-8986.2003.00149.x · Cited by 359
“Sample description. Depression severity was assessed with a 31-item modified version of the Hamilton Rating Scale for Depression (HRSD) modeled after the revision of the HRSD by Gelenberg et al. (1990) , with 19 of the items in this version directly addressing DSM–IV symptoms of depression (for details, see Allen et a…”
MethodThe GRID-HAMD: standardization of the Hamilton Depression Rating Scale
Williams, J. B. W., Kobak, K. A., Bech, P., Engelhardt, N., Evans, K., Lipsitz, J., Olin, J., Pearson, J., & Kalali, A. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3282f948f5 · Cited by 295
“, 1993) and expanded (Thase, 1984; Gelenberg et al., 1990) item sets.”
BackgroundStandardizing the Hamilton Depression Rating Scale: past, present, and future
Williams, J. B. W. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf03035120 · Cited by 293
Metadata
- Authors
- Gelenberg, A. J., Wojcik, J. D., Falk, W. E., Baldessarini, R. J., Zeisel, S. H., Schoenfeld, D., & Mok, G. S.
- Affiliations
- University of Arizona (US)
- Harvard University (US)
- McLean Hospital (US)
- Boston University (US)
- Corresponding author
- Gelenberg, Alan J.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 1990-06
- Volume
- 19
- Issue
- 2
- Pages
- 125-132
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2051796892
- Cited by
- 71
- References
- 14
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 2 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 3 · 2012: 2
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Affective Disorders (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- National Institutes of Health (5k05mh047370-25, 2r01mh036662-04)
- U.S. Public Health Service
- National Institute of Mental Health (MH-36662, P01MH031154, MH-31154, MH47370)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- tyrosine, major depressive disorder, imipramine, antidepressant efficacy, plasma amino acids, xerostomia, adverse effects, outpatients
- MeSH terms
- Adult, Depressive Disorder, Double-Blind Method, Female, Humans, Imipramine, Male, Methoxyhydroxyphenylglycol, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales, Tyrosine, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tyrosine for depression: a double-blind trial. https://app.cochat.ai/papers/10.1016/0165-0327(90)90017-3
- The paper
- Gelenberg, A. J., Wojcik, J. D., Falk, W. E., Baldessarini, R. J., Zeisel, S. H., Schoenfeld, D., & Mok, G. S. (1990). Tyrosine for depression: a double-blind trial. Journal of Affective Disorders. https://doi.org/10.1016/0165-0327(90)90017-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.